Brickell Biotech Inc (NASDAQ:BBI)
| 1.25 Delayed Data As of 4:00pm ET |  -0.08 / -6.02%Today’s Change | 0.47 Today|||52-Week Range 3.00 | +60.15% Year-to-Date |
Latest BBI News | Press Releases
| Will Brickell (BBI) Report Negative Earnings Next Week? What You Should Know 12:30pm / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 1.33 |
| Today’s open | 1.34 |
| Day’s range | 1.24 - 1.34 |
| Volume | 52,846 |
| Average volume (3 months) | 3,615,862 |
| Market cap | $63.7M |
Data as of 4:00pm ET, 03/02/2021
Growth & Valuation
| Earnings growth (last year) | +13.62% |
| Earnings growth (this year) | +84.22% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +388.10% |
| P/E ratio | NM |
| Price/Sales | 0.57 |
| Price/Book | 1.33 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NRBONeurobo Pharmaceutic... | +0.33 | +7.64% |
| ---- | ||
| SYNSynthetic Biologics ... | -0.02 | -3.37% |
| EDSAEdesa Biotech Inc | -0.04 | -0.62% |
Data as of 4:30pm ET, 03/02/2021
Financials
| Next reporting date | March 10, 2021 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $7.9M |
| Annual profit (last year) | -$23.9M |
| Net profit margin | -301.59% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Boulder, Colorado |
Forecasts
